newsfilter
← Latest News
ACCESS Newswire·

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. , a clinical-stage life sciences company that is focused on rebalancing inflammation, today